CXIX.—The formation and stability of spiro-compounds. Part I. spiro-Compounds from cyclo hexane

RM Beesley, CK Ingold, JF Thorpe - Journal of the Chemical Society …, 1915 - pubs.rsc.org
IN the series of investigations of which this coinmunicatioii is Part I, it is intended to ascertain
thel effect which is produced by the alteration of the tetrahedral angle, consequent 011 ring-…

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine …

…, A Akpabio, D Alpízar-Rodríguez, RP Beesley… - RMD open, 2022 - rmdopen.bmj.com
Objective We investigated prolonged COVID-19 symptom duration, defined as lasting 28
days or longer, among people with systemic autoimmune rheumatic diseases (SARDs). …

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

…, S Angevare, RP Beesley… - The Lancet …, 2022 - thelancet.com
Before widespread vaccination programmes, potential side-effects and flares after COVID-19
vaccination were frequent reasons for vaccine hesitancy among people with rheumatic …

[HTML][HTML] Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic …

…, S Surangiwala, L Thabane, RP Beesley… - The Lancet …, 2021 - thelancet.com
Background The impact and consequences of the COVID-19 pandemic on people with
rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance …

Impact of acute malaria on plasma concentrations of transferrin receptors

R Beesley, S Filteau, A Tomkins, T Doherty… - Transactions of the …, 2000 - Elsevier
The acute-phase response to infection alters the plasma concentrations of most biochemical
measures of iron status, rendering assessment of status difficult. Soluble transferrin …

[HTML][HTML] Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE …

…, IB McInnes, P Kearns, R Beesley… - The Lancet …, 2024 - thelancet.com
Background The humoral and T-cell responses to booster COVID-19 vaccine types in
multidisease immunocompromised individuals who do not generate adequate antibody responses …

Survey of adult and paediatric rheumatology patients suggests information about COVID-19 vaccination will aid uptake

RP Beesley, W Costello, SP Angevare… - …, 2021 - academic.oup.com
Dear Edi tor, The coronavirus disease 2019 (COVID-19) European Patient Registry (EPR) is
a longitudinal study [1] developed by parents of children and young people representing the …

Michael Beesley and cost benefit analysis

CD Foster - Journal of Transport Economics and Policy (JTEP), 2001 - ingentaconnect.com
… My purpose in this paper is to recall Michael Beesley’s great contribution to the development
of cost bene®t analysis (CBA), especially in transport. At the same time I try to infer and …

How can trial designs better serve the needs of children and young people with juvenile idiopathic arthritis?

FL Feilding, L Crosby, E Earle, R Beesley… - The Lancet …, 2024 - thelancet.com
In juvenile idiopathic arthritis we have seen remarkable progress in the number of available
licensed biological and small molecule treatments in the past two decades, leading to …

XCVIII.—Experiments on the rate of nitrification

RM Beesley - Journal of the Chemical Society, Transactions, 1914 - pubs.rsc.org
ALTHOUGH much work has previously been undertaken on the subject of nitrification, it has,
ils a rule, been either of a morphological nature or concerned more especially with the …